Pfizer (PFE) Tops Q3 EPS by 3c
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.87 +0.30%
Financial Fact:
Restructuring charges and certain acquisition-related costs: 531M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Restructuring charges and certain acquisition-related costs: 531M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.53 billion.
GUIDANCE:
- Pfizer sees FY2018 EPS of $2.98-$3.02, versus the consensus of $2.99.
- Now Expect to Repurchase Approximately $12 Billion of Shares in 2018
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, Guidance, Stock BuybacksRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
